Preview Mode Links will not work in preview mode

Feb 16, 2024

Featuring perspectives from Dr Bradley J Monk, including the following topics:

  • Introduction (0:00)
  • Case: A woman (gBRCA1) in her late 40s, 5 months after surgery and adjuvant paclitaxel/carboplatin for Stage II ovarian cancer, now with a single umbilical metastasis — Kellie E Schneider, MD (9:47)
  • Case: A woman...

Jan 24, 2024

Featuring perspectives from Dr Antonio González-Martín, including the following topics:

  • Introduction: Treatment-Related Second Cancers (0:00)
  • Case: A woman in her mid 40s (gBRCA) who presents with ascites and is diagnosed with high-grade serous ovarian cancer (HGSOC) with extensive peritoneal disease — Lyndsay J...

Dec 20, 2023

Featuring an interview with Dr David M O’Malley, including the following topics:

  • Prevalence of HER2 positivity among various gynecologic cancer subtypes; current testing recommendations (0:00)
  • Trastuzumab and other HER2-targeted therapies as a component of treatment for HER2-positive gynecologic cancers (15:17)
  • Key...

Nov 21, 2023

Featuring perspectives from Dr Richard T Penson and Dr Krishnansu S Tewari, including the following topics:

  • Introduction: Pan-tumor Indications for New Therapies (0:00)
  • Endometrial Cancer (14:13)
  • Treatment of Cervical Cancer (32:38)
  • Updates in Ovarian Cancer (45:41)

CME information and select...

Nov 3, 2023

Featuring perspectives from Prof Mitesh J Borad, Dr Anthony El-Khoueiry, Dr Christopher R Flowers, Dr Sara A Hurvitz, Dr Thomas E Hutson, Dr Amrita Krishnan, Dr Ann S LaCasce, Dr Heather McArthur, Dr Bradley J Monk, Dr Kathleen N Moore, Dr Robert Z Orlowski and Dr Guru P Sonpavde, moderated by Dr Neil Love, co-moderated...